ClinicalTrials.gg
Enrolling by invitationNCT05109689Updated Dec 30, 2024

A Randomized Controlled Trial of ACT-P Versus T4C for Community Reentry

An interventional study of ACT-P and T4C in Criminal Behavior and Violence, sponsored by Iowa State University. Enrolling by invitation at 1 site in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-30.

Sponsored by Iowa State University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 22 studies in Criminal Behavior with a site in United States — 4 open to participants now, 7 under way, none of them phase 3. Criminal Behavior · United States.

Planned enrollment
7th of 21
400 · median 200
Started
2022
with 1 other
No phase
20 of 22
3 open now
Registered
16th of 22
by date
Lead sponsor
1 of 22
Iowa State University

Among the 22 studies in Criminal Behavior with a site in United States, this one is the 7th largest by planned enrollment of the 21 interventional ones that give a count, is one of 2 that started in 2022, is one of 20 with no phase, and was the 16th registered.

Criminal Behavior

29 studies on the registry are indexed under Criminal Behavior; 8 are open to participants now.

Browse Criminal Behavior studies →

Open to participants now

4 of the 22 studies in Criminal Behavior with a site in United States are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 6 Criminal Behavior studies recruiting now, 2 set no upper age limit and 4 stop at 75 or younger; 3 take children under 18; 1 takes healthy volunteers.

This study: 18 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Criminal Behavior with a site in United States, or all of them as a file.
02

Study summary

The purpose of the proposed study is to determine the efficacy of Acceptance and Commitment Therapy for prisons (ACT-P) and Thinking for a Change (T4C) as reentry programs in a randomized controlled trial (RCT).

Read the detailed description

The proposed study will focus on medium to high risk adult males, currently institutionalized and approaching release, who will be randomized to Acceptance and Commitment Therapy for prisons (ACT-P) or the Thinking for a Change (T4C) program. ACT-P is a cognitive behavioral treatment that targets acceptance and mindfulness processes to reduce criminal behavior, and has been adapted for the prison setting. T4C is a widely used and well-established traditional cognitive behavioral program that targets changing criminal thinking.

The first aim of the study is to test the relative efficacy of the ACT-P intervention, compared to T4C, on recidivism. Recidivism will be measured in 3 ways: rearrests, reconvictions, and reincarceration during the 3 years post-release. A secondary aim is to test the theory of change and the proposed mechanisms of ACT-P and T4C. By focusing on the mechanisms that account for program success, it will provide insight into the theory of change underlying each program. Based on the theories underlying each treatment, we hypothesize differences in mechanisms of action between the two treatments. Given the emphasis in T4C on cognitive change, we predict stronger mediation effects in T4C for reductions in antisocial/criminal thinking. In contrast, we hypothesize that increases in psychological flexibility would be stronger mediators for ACT-P than for T4C.

03

Conditions studied

  • Criminal Behavior
  • Violence

Keywords

  • Cognitive behavior therapy
  • Community reentry
  • Recidivism
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • deemed medium or high risk according to the Iowa Risk Revised
  • eligible and appropriate for cognitive programming as determined by normal operating procedures

Exclusion criteria

Exclusion Criteria:

  • court-mandated to either program
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    ACT-P

    ACT-P is a cognitive behavioral program based on acceptance and commitment therapy, and it has been modified for use in the prison setting.

    Behavioral: ACT-P

  • Active comparator
    T4C

    Thinking for Change (T4C) is an evidence-based cognitive behavioral program focused on changing criminal thinking.

    Behavioral: T4C

Interventions

  • BehavioralACT-P

    ACT-P consists of five modules. The Big Picture sessions are interwoven throughout the 24 sessions to introduce the main concepts of the curriculum, such as values identification and awareness of criminal behaviors. The Emotion Regulation and Cognitive Skills modules focus on awareness of internal experiences; learning new ways to respond to internal experiences; identifying and stepping back from problematic/criminal thoughts and beliefs; awareness of behaviors in service of values versus behaviors in service of control/avoidance; and identifying steps for behavior change. The Behavioral Skills module focuses on practicing prosocial behaviors, such as speaking and listening effectively and conflict resolution. Finally, the Barriers to Change module addresses environmental or life circumstances that can hinder successful behavior change (e.g., toxic masculinity, substance use, and parenting difficulties).

  • BehavioralT4C

    T4C is an integrated cognitive behavioral change program authored by Drs. Jack Bush, Barry Glick, and Juliana Taymans under a cooperative agreement with the National Institute of Corrections (NIC). The program is based on the principle that thinking controls how people act, and that to change the way people act, they have to control their thinking. T4C systematically presents the concept that thoughts cause one's behavior, and offenders learn to identify their own thought patterns that lead to risky behavior, and then to replace those maladaptive thoughts with new ones. T4C incorporates research from cognitive restructuring theory, social skills development, and the learning and use of problem solving skills.

    Also known as: Thinking for a Change

06

What researchers measure

Primary outcomes

  1. Rearrests, convictions, and reincarcerations

    Criminal activity

    Time frame: 3 years post-release

07

Study locations

1 site
  • Fort Dodge Correctional Facility
    Fort Dodge, Iowa 50501, United States
08

References and documents

Individual participant data

Plan to share: Undecided — The investigators are undecided right now.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2022 (actual). Primary completion is estimated for Dec 2026, 58 months after the start.

Of 23 interventional studies with no phase under Criminal Behavior, half reached primary completion within 51 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 72. This study's planned 58 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 27, 2021
First posted
Nov 5, 2021
StartActual
Feb 21, 2022
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Dec 30, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05109689
Lead sponsor
Iowa State University
Responsible party
Amie Zarling (Associate Professor, Iowa State University) — Principal investigator
First posted
Nov 5, 2021
Start date
Feb 21, 2022
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Dec 30, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion